Boston Scientific has announced that it will be acquiring Apollo Endosurgery, manufacturers of minimally invasive weight-loss suturing systems and other products for gastrointestinal surgery in a deal worth approximately $615m.
The deal is priced at $10 a share – a 66% premium over its price for the past 30 days,...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?